Stock NRSN NEUROSENSE THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart NeuroSense Therapeutics Ltd.

Equities

NRSN

IL0011809592

Market Closed - Nasdaq
Other stock markets
 21:00:00 31/05/2024 BST 		5-day change 1st Jan Change
1.08 USD -.--% Intraday chart for NeuroSense Therapeutics Ltd. -7.46% +37.58%
05-14 NeuroSense Partners with PhaseV for ALS Treatment Trial -- Shares Up MT
05-07 NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NEUROSENSE THERAPEUTICS LTD. Stock NeuroSense Therapeutics Ltd.
 19.48M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. NRSN Stock
  4. Charts NeuroSense Therapeutics Ltd.
  5. Sector Chart